Evidence map›Paper›PMID 36557635›Full record

ReviewMicroorganisms2022

Raden Mohamad Rendy Ariezal Effendi, Muhammad Anshory, Handono Kalim, Reiva Farah Dwiyana, Oki Suwarsa, Luba M Pardo, Tamar E C Nijsten, Hok Bing Thio

Open access · goldAbstract readReview
In one paragraph

Review in Microorganisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 103 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
103citing papers in PubMed, 5 pooled it
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

103 citing papers in PubMed, 5 syntheses or guidelines pooled it, 145 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Review
  9. Review
  10. Article
  11. Review
  12. Applied and environmental microbiology · 2026
    Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review

43 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Raden Mohamad Rendy Ariezal EffendiDepartment of Dermatology, Erasmus MC, University Medical Center, 3015 GD Rotterdam, The Netherlands.ORCID 0000-0003-4471-0568
Muhammad AnshoryDepartment of Dermatology, Erasmus MC, University Medical Center, 3015 GD Rotterdam, The Netherlands.ORCID 0000-0003-2214-5238
Handono KalimDepartment of Internal Medicine, Faculty of Medicine Universitas Brawijaya, Malang 65145, Indonesia.
Reiva Farah DwiyanaDepartment of Dermatology and Venereology, Faculty of Medicine Universitas Padjadjaran-Dr. Hasan Sadikin Hospital, Bandung 45363, Indonesia.
Oki SuwarsaDepartment of Dermatology and Venereology, Faculty of Medicine Universitas Padjadjaran-Dr. Hasan Sadikin Hospital, Bandung 45363, Indonesia.
Luba M PardoDepartment of Dermatology, Erasmus MC, University Medical Center, 3015 GD Rotterdam, The Netherlands.ORCID 0000-0003-0684-3175
Tamar E C NijstenDepartment of Dermatology, Erasmus MC, University Medical Center, 3015 GD Rotterdam, The Netherlands.
Hok Bing ThioDepartment of Dermatology, Erasmus MC, University Medical Center, 3015 GD Rotterdam, The Netherlands.
Erasmus MC · NLDr. Hasan Sadikin General Hospital · IDUniversity of Brawijaya · ID

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Probiotics and synbiotics are used to treat chronic illnesses due to their roles in immune system modulation and anti-inflammatory response. They have been shown to reduce inflammation in a number of immune-related disorders, including systemic lupus erythematosus (SLE), human immunodeficiency virus (HIV), and chronic inflammatory skin conditions such as psoriasis and atopic dermatitis (AD).

Indexed as

Akkermansia muciniphilaatopic dermatitisFaecalibacterium prausnitziihuman immunodeficiency virusimmune-related diseasesimmunotherapyprobioticspsoriasissystemic lupus erythematosus

Identifiers

PMID36557635
PMCPMC9782003
OpenAlexW4311049397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.